STOCK TITAN

Nurix Therapeutics, Inc. (NRIX) Revenue by Year

NRIX

Nurix Therapeutics, Inc. generated $84.0M in revenue in fiscal year 2025. This represents an increase of 54.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $701.9M in revenue. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Nurix Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $84.0M
YoY +54.0%
5Y CAGR +36.3%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Aug 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NRIX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$701.9M$84.0M+54.0%$54.5M-29.1%$77.0M+99.3%$38.6M+29.8%$29.8M+66.9%$17.8M-42.7%$31.1M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

NRIX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$673.1M+8426.3%$9.0M-79.5%$6.3M-66.1%$13.6M+2.2%$7.9M-37.3%$44.1M+264.3%$18.5M+11.3%$13.3M-12.4%$12.6M-31.8%$12.1M-60.6%$16.6M+30.7%$15.2M+123.5%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Nurix Therapeutics, Inc. financials

Frequently Asked Questions

What was Nurix Therapeutics, Inc.'s revenue in fiscal year 2025?

Nurix Therapeutics, Inc. generated $84.0M in revenue in fiscal year 2025.

How fast is Nurix Therapeutics, Inc.'s revenue growing?

Nurix Therapeutics, Inc. (NRIX) revenue rose by 54.0% year over year, from $54.5M to $84.0M in fiscal year 2025.

What is Nurix Therapeutics, Inc.'s revenue over the last twelve months?

Nurix Therapeutics, Inc. (NRIX) reported $701.9M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 7 fiscal years this page covers, Nurix Therapeutics, Inc. (NRIX) revenue went from $31.1M in fiscal year 2019 to $84.0M in fiscal year 2025.

Nurix Therapeutics, Inc. (NRIX) reported $673.1M in revenue in Q3 2026. This represents an increase of 8426.3% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Nurix Therapeutics, Inc. (NRIX) reported on that line in every period on record.